Nano-X Imaging Ltd. (NNOX)
| Market Cap | 134.31M -61.6% |
| Revenue (ttm) | 13.02M +15.4% |
| Net Income | -75.02M |
| EPS | -1.16 |
| Shares Out | 69.59M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,365,950 |
| Open | 2.030 |
| Previous Close | 2.070 |
| Day's Range | 1.900 - 2.060 |
| 52-Week Range | 1.590 - 5.720 |
| Beta | 1.17 |
| Analysts | Strong Buy |
| Price Target | 7.20 (+273.06%) |
| Earnings Date | Jun 16, 2026 |
About NNOX
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to ... [Read more]
Financial Performance
In 2025, Nano-X Imaging's revenue was $13.02 million, an increase of 15.40% compared to the previous year's $11.28 million. Losses were -$75.02 million, 40.2% more than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for NNOX stock is "Strong Buy." The 12-month stock price target is $7.2, which is an increase of 273.06% from the latest price.
News
Nano-X Imaging enters Peruvian market in distribution pact with Top Med
Nanox Imaging announced a distribution agreement with Top Med to deploy the Nanox.ARC system and related services in Peru. Under the agreement, Nanox appointed Top Med as its exclusive distributor…
Exclusive distribution agreement marks Nanox's entry into the Peruvian market
Initial deployment is expected to include six Nanox.ARC systems under a capex model PETACH TIKVA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (“Nanox”, or the “Company” NASDAQ: NNOX),...
Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems
Advances Nanox's ongoing U.S. commercialization and deployment efforts PETACH TIKVA, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Nano X Imaging Ltd. (“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in...
Nano-X Imaging signs distribution agreement with Radiology Oncology Systems
Nano-X Imaging (NNOX) announced that its U.S.-based subsidiary, Nanox Impact, has signed a distribution agreement with Radiology Oncology Systems to distribute its Nanox.ARC systems across the United ...
Nano-X Imaging price target lowered to $5 from $7 at Alliance Global
Alliance Global lowered the firm’s price target on Nano-X Imaging (NNOX) to $5 from $7 and keeps a Buy rating on the shares. The company reported Q4 results that were…
Nano-X Imaging reports Q1 adjusted EPS (17c), consensus (15c)
Reports Q1 revenue $3.72M, consensus $3.99M.
Nano-X Imaging still sees FY26 revenue $35M, cosnensus $31.58M
Nano-X Imaging (NNOX) said: “The Company’s current revenue base remains at an early stage, and the timing and pace of revenue growth are expected to depend primarily on the timing…
Nano-X Imaging announces resignation of CFO Ran Daniel
CFO Ran Daniel has decided to step down from his position, effective July 31, 2026, after five years with the Company. Mr. Daniel will remain with the Company for a…
Nano-X Imaging announces commercial agreement with Howard Technology
Nano-X Imaging (NNOX) announced a strategic commercial agreement with Howard Technology Solutions. The agreement will support the commercial rollout of the Nanox.ARC, an FDA-cleared, multisource digit...
Nano-X Imaging Earnings Call Transcript: Q4 2025
Q4 2025 saw expanded commercial agreements, a strategic acquisition, and a major manufacturing shift, driving a 23% revenue increase year-over-year. The company targets $35M revenue for 2026, with most growth expected in the second half as deployments ramp up.
Nano-X Imaging Earnings release: Q4 2025
Nano-X Imaging released its Q4 2025 earnings on April 20, 2026, summarizing the period's financial results.
Nano-X Imaging Annual report: Q4 2025
Nano-X Imaging has published its Q4 2025 annual report on April 20, 2026.
Nanox.ARC X Digital Advanced 3D imaging built for access and powered by innovation Wins 2026 Red Dot Award for Product Design
International Red Dot Jury recognizes Nanox.ARC X for design excellence that brings advanced 3D tomosynthesis imaging into a wider range of clinical settings
Nano-X Imaging announces clinical collaboration with Meir Medical Center
Nanox Imaging announced a clinical collaboration with Meir Medical Center, part of the Clalit Health Services. The clinical study is designed to demonstrate the diagnostic value of the Nanox.ARC syste...
Nano-X Imaging subsidiary signs distribution pact with Digital X-Ray Imaging
Nano X Imaging announced that its U.S.-based subsidiary, Nanox Impact, has signed a new distribution agreement with Digital X-Ray Imaging. The agreement will support the deployment of the Nanox.ARC, a...
Nanox Signs Distribution Agreement with Digital X-Ray Imaging to Expand Nanox.ARC Adoption in Arkansas
Fourth distribution agreement of 2026 strengthens Nanox's U.S. commercial momentum PETACH TIKVA, Israel, April 13, 2026 (GLOBE NEWSWIRE) -- Nano X Imaging Ltd. (NASDAQ NNOX), a leader in innovative me...
Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026
PETACH TIKVA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will rep...
Nanox Signs Distribution Agreement with Integrity Medical Service, Inc. to Deploy Nanox.ARC Systems
New regional partnership strengthens Nanox 's presence and service support across outpatient imaging settings in Colorado , Wyoming and the western parts of Kansas and Nebraska
Nano-X Imaging signs distribution deal with Elite Surgical Technologies
Nanox Impact, a subsidiary of Nano-X Imaging (NNOX), announced that it has signed a new distribution agreement with Elite Surgical Technologies. “As we are building momentum in the U.S. and…
Nano-X Imaging Registration statement: Registration filing
Nano-X Imaging filed a registration statement on March 26, 2026, providing details about a securities offering with the SEC.
Nano-X Imaging Transcript: Investor Summit Virtual Conference
The presentation highlighted the company's FDA- and CE-cleared 3D imaging systems, innovative cold cathode technology, and expanding AI/software division. Commercialization is advancing in the U.S. and Europe, with flexible business models and strong operator margins.
Nano-X Imaging files $100M mixed securities shelf
17:21 EDT Nano-X Imaging (NNOX) files $100M mixed securities shelf
Nano-X Imaging Registration statement: Registration Filing
Nano-X Imaging filed a registration statement on March 13, 2026, providing details about a securities offering with the SEC.
Nano-X Imaging signs distribution agreement with Imperial Imaging Technology
Nano-X Imaging (NNOX) announced that its US-based subsidiary, Nanox Impact has signed a new distribution agreement with Imperial Imaging Technology, a Georgia based provider of diagnostic imaging solu...
Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast
Agreement with Imperial Imaging strengthens Nanox's commercial rollout across the orthopedic-rich segment in six U.S. Southeast states.